Clinical Trial Update: A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of cetuximab in patients with stage IV colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED